What happened, in summary

Angela George was 42 when family history led her to take a closer look at her cancer risk. Her father had recently been diagnosed with colon cancer, and several relatives had also had cancer, including her mother and grandmother with breast cancer. In July 2020, genetic testing and a more detailed breast cancer risk assessment showed Angela’s lifetime breast cancer risk was high. A regular mammogram in June 2020 had been normal, but because of that risk she began alternating mammograms and MRIs every 6 months. Her first MRI, on Christmas Eve 2020, found abnormalities in both breasts. Biopsies on January 4, 2021 led to a Stage I breast cancer diagnosis in the left breast on January 7. Because the cancer was described as aggressive, treatment moved quickly. Within 3 weeks, Angela had a bilateral mastectomy. About 1 month later, she started chemotherapy: 6 rounds over about 5 months. She then completed 1 year of Herceptin infusions and later had an oophorectomy. As of September 2025, Angela was approaching the 5-year anniversary of diagnosis. Active treatment was behind her, but she remained on a daily medication to reduce estrogen and saw her oncologist every 6 months. Her latest status was described cautiously, without a stated no-evidence-of-disease result.